Asia-Pacific In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Asia-Pacific In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Asia-Pacific In-Vitro Fertilization (IVF) Market Introduction and Overview

According to SPER market research, ‘Asia-Pacific In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’state that the Asia-Pacific In-Vitro Fertilization (IVF) Market is predicted to reach USD 63.52 Billion by 2033 with a CAGR of 17.24%.

The term “in vitro fertilisation” (IVF) is a medical procedure where sperm fertilise an egg outside of the body. Couples who have not been able to conceive naturally because of infertility, reproductive problems, or genetic issues are usually the ones who use this approach. IVF tests, which include a variety of diagnostic procedures and assessments to assist identify potential problems, optimise treatment plans, and raise the odds of successful fertilisation and pregnancy, are an essential element of the IVF process.

The Asia-Pacific IVF services industry is expected to grow more slowly as a result of the COVID-19 pandemic. Numerous nations implemented statewide lockdowns, which had a direct effect on fertility tourism due to the cancellation of flights, travel restrictions and quarantines, prohibitions on holding any kind of indoor or outdoor event, and declarations of emergencies. Growth in the market is hampered by a decline in infertility consultations and a large decline in revenue during COVID-19.

Scope of the Report:

Report Metric Details
Market size available for years 2019-2033
Base year considered 2022
Forecast period 2023-2033
Segments covered By Cycle Type, By End User
Regions covered Australia, China, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Rest of Asia-Pacific

Companies Covered

Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others

APAC In-Vitro Fertilization (IVF) Market Segmentation

By Cycle Type:Based on the Cycle Type, Asia-Pacific In-Vitro Fertilization (IVF) Market is segmented as; Donor Egg IVF Cycle, Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor).

By End User:Based on the End User, Asia-Pacific In-Vitro Fertilization (IVF) Market is segmented as; Clinical Research Institutes, Fertility Clinics, Hospitals, Surgical Centers.

By Region:This research also includes data for Australia, China, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Rest of Asia-Pacific.